IL-10 mediates susceptibility to Trypanosoma cruzi infection - PubMed (original) (raw)
. 1994 Oct 1;153(7):3135-40.
Affiliations
- PMID: 8089491
IL-10 mediates susceptibility to Trypanosoma cruzi infection
S G Reed et al. J Immunol. 1994.
Abstract
IL-10 has been shown to inhibit some aspects of macrophage activation, including the in vitro IFN-gamma-mediated intracellular killing of the protozoan parasite Trypanosoma cruzi. We have previously shown that genetically susceptible mice produced more IL-10 during T. cruzi infection than resistant mice, suggesting an association between IL-10 production and disease susceptibility. In the present study, such an association was documented. IL-10 mRNA was present in the spleens of susceptible C57BL/6 mice, but not in resistant (C57BL/6 x DBA/2) F1 mice, as early as 2 days after infection with T. cruzi. In susceptible mice, IL-10 mRNA was found in enriched populations of splenic T cells and peritoneal macrophages by 4 days after infection. By 14 days after infection, IL-10 mRNA was detected in enriched populations of splenic T cells and peritoneal macrophages, as well as by splenic B cells and macrophages. In SCID mice infected with T. cruzi, IL-10 mRNA was detected in peritoneal cells 2 days after infection. The IL-10 mRNA production was not abolished by treatment with anti-asialo GM-1 Ab before infection, which is consistent with its production by macrophages. Finally, the role of endogenous IL-10 production in the susceptibility to T. cruzi infection was demonstrated by the protection of highly susceptible C57BL/6 mice against acute disease and death from T. cruzi by the administration of neutralizing anti-IL-10 mAb. This study demonstrated an important and perhaps essential role of IL-10 in mediating in vivo susceptibility to T. cruzi infection.
Similar articles
- [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL, Antúnez MI, Abrami AA. Cardoni RL, et al. Medicina (B Aires). 1999;59 Suppl 2:84-90. Medicina (B Aires). 1999. PMID: 10668248 Spanish. - [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
Laucella SA, Rottenberg ME, de Titto EH. Laucella SA, et al. Rev Argent Microbiol. 1996 Apr-Jun;28(2):99-109. Rev Argent Microbiol. 1996. PMID: 8768488 Review. Spanish. - How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi?
Umekita LF, Mota I. Umekita LF, et al. Braz J Med Biol Res. 2000 Mar;33(3):253-8. doi: 10.1590/s0100-879x2000000300001. Braz J Med Biol Res. 2000. PMID: 10719375 Review.
Cited by
- Effectiveness of Nitazoxanide and Electrolyzed Oxiding Water in Treating Chagas Disease in a Canine Model.
Rodríguez-Morales O, Mendoza-Téllez EJ, Morales-Salinas E, Arce-Fonseca M. Rodríguez-Morales O, et al. Pharmaceutics. 2023 May 12;15(5):1479. doi: 10.3390/pharmaceutics15051479. Pharmaceutics. 2023. PMID: 37242721 Free PMC article. - The Role of MIF and IL-10 as Molecular Yin-Yang in the Modulation of the Host Immune Microenvironment During Infections: African Trypanosome Infections as a Paradigm.
Stijlemans B, Schoovaerts M, De Baetselier P, Magez S, De Trez C. Stijlemans B, et al. Front Immunol. 2022 Apr 7;13:865395. doi: 10.3389/fimmu.2022.865395. eCollection 2022. Front Immunol. 2022. PMID: 35464430 Free PMC article. Review. - Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease.
Carrillo I, Rabelo RAN, Barbosa C, Rates M, Fuentes-Retamal S, González-Herrera F, Guzmán-Rivera D, Quintero H, Kemmerling U, Castillo C, Machado FS, Díaz-Araya G, Maya JD. Carrillo I, et al. PLoS Negl Trop Dis. 2021 Nov 16;15(11):e0009978. doi: 10.1371/journal.pntd.0009978. eCollection 2021 Nov. PLoS Negl Trop Dis. 2021. PMID: 34784372 Free PMC article. - Albendazole-Schisandrin B Co-Therapy on _Angiostrongylus cantonensis_-Induced Meningoencephalitis in Mice.
Lam HYP, Liang TR, Jiang SJ, Peng SY. Lam HYP, et al. Biomolecules. 2020 Jul 5;10(7):1001. doi: 10.3390/biom10071001. Biomolecules. 2020. PMID: 32635653 Free PMC article. - Metabolic syndrome agravates cardiovascular, oxidative and inflammatory dysfunction during the acute phase of Trypanosoma cruzi infection in mice.
Lucchetti BFC, Boaretto N, Lopes FNC, Malvezi AD, Lovo-Martins MI, Tatakihara VLH, Fattori V, Pereira RS, Verri WA Jr, de Almeida Araujo EJ, Pinge-Filho P, Martins-Pinge MC. Lucchetti BFC, et al. Sci Rep. 2019 Dec 11;9(1):18885. doi: 10.1038/s41598-019-55363-9. Sci Rep. 2019. PMID: 31827186 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases